Drug class
Antipsoriatics
Antipsoriatics are a therapeutic class of dermatological medications formulated to control and alleviate the cutaneous manifestations of psoriasis and related hyperkeratotic skin disorders. Read more about Antipsoriatics
235 drugs in this class 67 manufacturers
Drugs in Antipsoriatics
SPEVIGO (spesolimab-sbzo)
SOTYKTU (deucravacitinib)
AMJEVITA AUTOINJECTOR (adalimumab-atto)
AMJEVITA(CF) (adalimumab-atto)
AMJEVITA(CF) AUTOINJECTOR (adalimumab-atto)
AMJEVITA(CF) AUTOINJECTOR (adalimumab-atto)
IDACIO(CF) (adalimumab-aacf)
CYLTEZO(CF) (adalimumab-adbm)
Antipsoriatics are a therapeutic class of dermatological medications formulated to control and alleviate the cutaneous manifestations of psoriasis and related hyperkeratotic skin disorders.
Administered topically or systemically, agents in this class—such as vitamin D3 analogues, retinoids, anthracen derivatives, and psoralens—work primarily by normalizing keratinocyte proliferation and differentiation, decreasing epidermal hyperkeratosis, and dampening localized inflammatory pathways.
Their principal clinical application is the management of mild-to-severe plaque psoriasis and related dermatologic conditions.
While this classic therapeutic grouping focuses on traditional topical and systemic therapies, broader systemic management of psoriatic disease also overlaps with targeted immunomodulators and biologics.
-
wikipedia.org
Antipsoriatics are a therapeutic class of dermatological medications formulated to control and alleviate the cutaneous manifestations of psoriasis and related hyperkeratotic skin disorders Administered topically or systemically, agents in this class—such as vitamin D3 analogues, retinoids, anthracen derivatives, and psoralens—work primarily by normalizing keratinocyte proliferation and differentiation, decreasing epidermal hyperkeratosis, and dampening localized inflammatory pathways
-
fhi.no
Antipsoriatics are a therapeutic class of dermatological medications formulated to control and alleviate the cutaneous manifestations of psoriasis and related hyperkeratotic skin disorders Administered topically or systemically, agents in this class—such as vitamin D3 analogues, retinoids, anthracen derivatives, and psoralens—work primarily by normalizing keratinocyte proliferation and differentiation, decreasing epidermal hyperkeratosis, and dampening localized inflammatory pathways Their princ...
-
fda.gov
Their principal clinical application is the management of mild-to-severe plaque psoriasis and related dermatologic conditions
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.